NPS PHARMACEUTICALS INC
NPSP
NPSP was delisted on the 20th of February, 2015.
210 hedge funds and large institutions have $2.9B invested in NPS PHARMACEUTICALS INC in 2014 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 81 increasing their positions, 77 reducing their positions, and 19 closing their positions.
116% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 19
10% more funds holding
Funds holding: 191 → 210 (+19)
5% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 77
3% less capital invested
Capital invested by funds: $2.98B → $2.9B (-$79M)
17% less call options, than puts
Call options by funds: $18.5M | Put options by funds: $22.2M
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$56M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$53M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$26.9M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$13.8M |
| 5 |
TA
Teachers Advisors
New York
|
+$12.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$48.8M |
| 2 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$29.8M |
| 3 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$23.9M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$20M |
| 5 |
PC
PointState Capital
New York
|
-$15.2M |
NPSP Hedge Fund Activity: Q1 2014 in Review
210 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q1 2014, worth a combined $2.9B — down 2.6% from $2.98B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new NPSP positions and 19 closed out — a net gain of 22 holders — while 81 added to existing stakes and 77 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $56M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $48.8M sold.
- 210 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q1 2014, up from 191 in Q4 2013.
- Funds reported $2.9B of NPS PHARMACEUTICALS INC stock for Q1 2014, down 2.6% quarter-over-quarter.
- 41 funds opened new NPS PHARMACEUTICALS INC positions in Q1 2014 and 19 closed out, a net change of +22 holders.
- The largest NPS PHARMACEUTICALS INC buyer in Q1 2014 was Wellington Management Group, an estimated $56M added.
- The largest NPS PHARMACEUTICALS INC seller in Q1 2014 was Westfield Capital Management, an estimated $48.8M sold.
Based on aggregated 13F filings for Q1 2014.